Ozempic and Wegovy usage are booming for weight loss, but some patients report surprising side effects—like sagging ...

Days before Ozempic’s India debut, Centre cautions that GLP-1 drugs carry unknown long-term risks and are being adopted ...

In early 2025, the British Medical Journal (BMJ) reported 82 UK deaths from adverse reactions to semaglutide and tirzepatide, ...

A MUM who feared having kids “ruined” her body has managed to shrink a whopping five dress sizes after taking fat jabs. Carly ...

The mortgage market is hotting up as NatWest becomes the latest high street giant to unleash rate cuts. Brokers say lenders ...

A steep price drop for Wegovy and strong uptake of Mounjaro pushed GLP-1 weight-loss drugs to new highs in November. The ...

Earlier, the court had declined Novo’s plea for an interim injunction against Dr Reddy’s Labs and permitted the company to ...

We have an emerging new entrant in the increasingly crowded weight loss drug space.

A onetime bull now feels the stock is only a hold. Novo Nordisk (NYSE: NVO) stock was slimming down on Monday, but not in the ...

This is precisely why Dr Debra Marcos, chief medic at Weight Medics, is calling on patients to completely overhaul their ...

Semaglutide medications like Ozempic and Wegovy can help lower the risk of heart and metabolic diseases in people with ...

Dr Debra Marcos said festive favourites are the type of foods that do not sit well with a slowed digestive system ...